SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge. (2022)

First Author: Sullivan E
Attributed to:  A reverse vaccinology approach to a bTB vaccine funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/v14050914

PubMed Identifier: 35632656

Publication URI: http://europepmc.org/abstract/MED/35632656

Type: Journal Article/Review

Volume: 14

Parent Publication: Viruses

Issue: 5

ISSN: 1999-4915